FDA Approves New CooperVision Biofinity® toric multifocal Contact Lenses

The U.S. Food and Drug Administration (FDA) has granted CooperVision, Inc. approval for its new Biofinity® toric multifocal contact lenses.

The product combines the proven optical designs of CooperVision’s Biofinity toric and Biofinity multifocal to provide patients with both astigmatism and presbyopia vision correction. The company plans to make the lenses available to U.S. eye care professionals later this year, followed by other markets.

“Biofinity® toric multifocal extends the reliable performance of our Biofinity® toric lenses to presbyopic patients,” said Michele Andrews, OD, Senior Director, Professional and Academic Affairs, North America, CooperVision. “U.S. eye care professionals will soon have an easy-to-fit, familiar lens design they can count on to keep current toric wearers satisfied in contact lenses for longer, and provide new astigmatic wearers an alternative to reading glasses. It’s a win-win for practitioners and their patients.”

Lens parameters and other details regarding Biofinity® toric multifocal will be made public in the coming months.

Source: CooperVision

Featured Posts

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read More

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read More

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read More

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more